GlassScriptPhysician profile
Koushik K Shaw
NPI 1811954423
$30,214.56
in general payments reported to CMS, 2019-2025
45 companies · $12K in 2025
The $12K reported for 2025 was more than what 95% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,842 · 2020: $1,134 · 2021: $1,609 · 2022: $2,673 · 2023: $1,528 · 2024: $2,267 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,735 · Consulting Fee: $5,250 · Travel and Lodging: $2,971.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,734.85 |
| Consulting Fee | $5,250.00 |
| Travel and Lodging | $2,971.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $13,388.46 | 2019-2025 | Aquabeam System, Aquabeam Robotic System |
| Intuitive Surgical, INC. | $4,171.48 | 2019-2023 | Da Vinci Surgical System |
| Axonics, INC. | $3,450.08 | 2020-2024 | Axonics, Bulkamid |
| Neotract INC. | $1,811.09 | 2019 | |
| Teleflex LLC | $1,543.21 | 2021-2025 | Urolift, Barrigel |
| Boston Scientific Corporation | $1,030.21 | 2019-2025 | Axonics, Lithovue, Rezum Generator |
| Abbvie INC. | $590.73 | 2019-2025 | Botox |
| Allergan, INC. | $496.32 | 2019-2022 | |
| Biotissue Holdings INC. | $445.39 | 2023-2025 | |
| Endo Pharmaceuticals INC. | $368.47 | 2019-2024 | Xiaflex, Aveed |
| Pfizer INC. | $309.03 | 2019-2025 | |
| Astellas Pharma US INC | $238.81 | 2019-2022 | |
| Clarus Therapeutics INC. | $177.16 | 2021 | |
| Urogen Pharma, INC. | $172.35 | 2020-2023 | Jelmyto |
| Olympus America INC. | $153.35 | 2021-2025 | Itind System |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $144.43 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $139.08 | 2025 | Adstiladrin |
| Srs Medical Systems, INC. | $137.13 | 2023-2024 | Urocuff, Urocuff-Dc Disposable, Single, Ct3000 Pro Base Unit |
| Endo USA, INC. | $121.74 | 2024-2025 | Xiaflex, Aveed |
| Coloplast Corp | $117.20 | 2019-2024 | Speedicath |
| Karl Storz Lithotripsy-America | $115.66 | 2019 | |
| Valencia Technologies Corporation | $113.92 | 2025 | Ecoin Device Kit |
| Antares Pharma, INC. | $101.66 | 2019-2022 | |
| Myriad Genetic Laboratories, INC. | $94.87 | 2021-2023 | Prolaris, Myrisk |
| Caldera Medical, INC | $86.03 | 2022 | |
| Edap Technomed INC | $83.33 | 2022 | |
| Sumitomo Pharma America, INC. | $81.14 | 2025 | Orgovyx |
| Becton, Dickinson and Company | $80.00 | 2022 | |
| Myovant Sciences INC. | $60.29 | 2021 | |
| Abbott Laboratories | $38.99 | 2019-2025 | Proclaim |
| Ethicon US, LLC | $38.84 | 2019-2022 | |
| Calyxo, INC. | $36.84 | 2025 | Cvac Aspiration System |
| Acerus Pharmaceuticals Corporation | $31.60 | 2021-2022 | |
| Agiliti Surgical, INC. | $29.39 | 2025 | Sonablate Hifu, Koelis Trinity Mri/US Fusion |
| Dendreon Pharmaceuticals LLC | $28.57 | 2025 | Provenge |
| Telix Pharmaceuticals | $28.32 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.04 | 2025 | |
| Zyla Life Sciences, INC. | $22.60 | 2020 | |
| Conmed Corporation | $19.62 | 2021 | |
| Mission Pharmacal Company | $19.01 | 2019 | |
| Exeltis, USA INC. | $18.81 | 2022 | |
| Civco Medical Instruments | $17.86 | 2024 | |
| Laborie Medical Technologies Corp. | $14.10 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Amag Pharmaceuticals, INC. | $12.14 | 2019 | |
| Lupin INC. | $11.21 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Koushik Shaw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.